These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 33786278

  • 21. [Relationship between autoantibodies and HLA-DQ genotypes in patients with type 1 diabetes mellitus].
    Wang JP, Zhang C, Lin J, Yuan Y, Zhou HF, Huang G, Zhou M, Zhou ZG.
    Zhonghua Yi Xue Za Zhi; 2007 Sep 11; 87(34):2380-4. PubMed ID: 18036312
    [Abstract] [Full Text] [Related]

  • 22. New-onset type 1 diabetes mellitus as a delayed immune-related event after discontinuation of nivolumab: A case report.
    Seo JH, Lim T, Ham A, Kim YA, Lee M.
    Medicine (Baltimore); 2022 Sep 02; 101(35):e30456. PubMed ID: 36107574
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Number of autoantibodies and HLA genotype, more than high titers of glutamic acid decarboxylase autoantibodies, predict insulin dependence in latent autoimmune diabetes of adults.
    Maioli M, Pes GM, Delitala G, Puddu L, Falorni A, Tolu F, Lampis R, Orrù V, Secchi G, Cicalò AM, Floris R, Madau GF, Pilosu RM, Whalen M, Cucca F.
    Eur J Endocrinol; 2010 Oct 02; 163(4):541-9. PubMed ID: 20603341
    [Abstract] [Full Text] [Related]

  • 25. HLA Risk Haplotype: Insulin Deficiency in Pediatric Type 1 Diabetes.
    Gómez-Díaz RA, Nishimura-Meguro E, Garrido-Magaña E, Lizárraga-Paulin L, Aguilar-Herrera BE, Bekker-Méndez C, Medina-Santillán R, Barquera R, Mondragón-González R, Wacher NH.
    Rev Invest Clin; 2016 Oct 02; 68(3):128-36. PubMed ID: 27408999
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. A case of nivolumab-induced acute-onset type 1 diabetes mellitus in melanoma.
    Sakaguchi C, Ashida K, Yano S, Ohe K, Wada N, Hasuzawa N, Matsuda Y, Sakamoto S, Sakamoto R, Uchi H, Furue M, Nomura M, Ogawa Y.
    Curr Oncol; 2019 Feb 02; 26(1):e115-e118. PubMed ID: 30853818
    [Abstract] [Full Text] [Related]

  • 29. A Case in Which HLA-DR4 is Involved in the Development of Complex Immune-Related Endocrinological Adverse Events following Combination Therapy with Nivolumab and Ipilimumab.
    Kidawara Y, Kadoya M, Kakutani-Hatayama M, Koyama H.
    Case Rep Endocrinol; 2024 Feb 02; 2024():4662803. PubMed ID: 38559614
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Prevalence of β-cell antibodies and associated autoimmune diseases in children and adolescents with type 1 diabetes (T1DM) versus type 2 diabetes (T2DM) in Qatar.
    Alyafei F, Soliman A, Alkhalaf F, Sabt A, De Sanctis V, Elsayed N, Waseef R.
    Acta Biomed; 2018 May 23; 89(S5):32-39. PubMed ID: 30049930
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Glutamic Acid Decarboxylase Autoantibody-negative Slowly Progressive Type 1 Diabetes Mellitus: A Case Report and Literature Review.
    Kobayashi M, Ohara N, Ikeda Y, Nagano O, Takada T, Kodama M, Sone H.
    Intern Med; 2018 Dec 15; 57(24):3581-3587. PubMed ID: 30101912
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Diabetic Ketoacidosis as a Delayed Immune-Related Event after Discontinuation of Nivolumab.
    Mae S, Kuriyama A, Tachibana H.
    J Emerg Med; 2021 Mar 15; 60(3):342-344. PubMed ID: 33097350
    [Abstract] [Full Text] [Related]

  • 40. Non-insulin-dependent Diabetes Mellitus Induced by Immune Checkpoint Inhibitor Therapy in an Insulinoma-associated Antigen-2 Autoantibody-positive Patient with Advanced Gastric Cancer.
    Ohara N, Kobayashi M, Ikeda Y, Hoshi T, Morita S, Kanefuji T, Yagi K, Suda T, Takada T, Hasegawa G, Sato Y, Hirano K, Kosugi SI.
    Intern Med; 2020 Feb 15; 59(4):551-556. PubMed ID: 31708539
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.